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Background: Accelerated idioventricular rhythm (AIVR) is a common arrhythmia observed in
patients with ST segment elevation myocardial infarction (MI). It is not clear how much
value AIVR has in predicting successful reperfusion, since there have been conﬂicting data
regarding this in the past. Streptokinase (STK) even today is the commonest thrombolytic
agent used in the public health care set-up in India.1Most data for the use of STK are from the
1990s, which had showed that at best it is effective in only 50% of patients in restoring
adequate ﬂow.2 It is probable that with the current dual-antiplatelet loading dose regimen
and other newer medications, this ﬁgure could be higher. Also, rescue angioplasty for failed
thrombolysis is the standard of care now, unlike before. Hence, we need reliable non-
invasive markers to judge successful reperfusion in the present era. While ST segment
resolution is the standard marker for reperfusion used in thrombolytic trials, in several
instances it is not deﬁnitive. An additional marker would thus be very useful, especially in
such cases.
Methods: This was a prospective observational study carried out at a public teaching
hospital. 200 consecutive patients with a diagnosis of acute MI who were given STK within
12 h of index pain were included. The STK dose was 1.5 million units, infused over 30 min;
the ECG was again recorded after 90 min of completion of the infusion. Continuous ECG
monitoring for the ﬁrst 24 h of ICCU stay was performed and AIVRs during this period were
documented. Early AIVR was deﬁned as that occurring within 2 h of completing the STK
infusion. Echocardiography was performed 24 h after presentation. The time course of AIVR
was studied vis-a-vis the outcome of thrombolysis.
Results: AIVR was seen in 41% of the patients. Though AIVR was found to have low
sensitivity (45%) and speciﬁcity (64%) as a predictor of successful thrombolysis, early AIVR
was a reliable sign of successful thrombolysis ( p < 0.05). The sensitivity (45%) of early AIVR
was low; however, the speciﬁcity (94%) and positive predictive value (94%) were very good.
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Conclusion: AIVR is a common arrhythmia in the setting of STEMI receiving thrombolytic
therapy. Early AIVR is more common with successful thrombolysis, with an excellent
positive predictive value. Thus, early AIVR can be used as an additive criterion to ST
segment resolution as a non-invasive marker of successful thrombolysis with STK.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
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Fig. 1 – Successful reperfusion. Lead III from a patient with
an inferior wall MI. Panel A shows ST elevation of 7 mm,
measured 40 ms after J point. Panel B shows successful
reperfusion with reduction of ST elevation to 3 mm.1. Introduction
AIVR was ﬁrst described by Thomas Lewis in 1910. It is
commonly observed in patients with ST segment elevation MI
(STEMI), is generally a transient rhythm, mostly hemody-
namically stable, and rarely requiring treatment. AIVR has
been noted to be a marker of reperfusion, but conﬂicting data
abound regarding the same.3–8 In the past, STK was the
commonest thrombolytic agent used worldwide. Over the last
two decades, newer thrombolytic agents and primary
angioplasty (PAMI) have eclipsed STK in large parts of the
world. As the cost of tissue plasminogen activator (t-PA) is
manyfold compared with STK, the latter continues to be the
thrombolytic agent of choice in most public hospitals in India.
Data pertaining to use of STK are mostly from trials done 2
decades ago. Older angiographic studies2 have shown STK to
be effective in only 50% of patients in restoring adequate
coronary ﬂow. In that era, loading with dual antiplatelets was
not the norm, as it is now. Other medications often used
currently such as nicorandil were not available then. Thus,
there is a need to reassess the efﬁcacy of STK in today's
scenario. Moreover, for failed thrombolysis, rescue angio-
plasty is today the standard of care, while it was not so two
decades ago. It is therefore crucial to noninvasively diagnose
failed thrombolysis. This study therefore aimed at assessing
whether AIVR is an indicator of successful reperfusion with
STK.
2. Method
This study was carried out at a large teaching hospital in
Mumbai. 200 patients admitted to the intensive care unit with
acute STEMI who were administered STK were included. All
patients were monitored by continuous ECG monitoring for
24 h. 12 lead ECGs were obtained on admission, 90 min after
STK and on occurrence of AIVR. All patients were evaluated by
echocardiography. The chi-square test of signiﬁcance was
applied for statistical analysis of AIVR in patients with
successful and failed thrombolysis.
Exclusion criterion: Prior MI, bundle branch block.
Deﬁnitions: Successful thrombolysis – ST segment resolu-
tion to <50% from initial ST elevation in the lead
showing maximum elevation initially (Fig. 1). AIVR – At
least 3 consecutive ventricular complexes, which are faster
than the sinus rhythm, but slower than 120/min (Fig. 2).
Early AIVR: Occurring within 2 h of completion of STK
infusion.3. Results
Successful thrombolysis with STK was achieved in 113/200
patients (57%). Older STK trials have reported successful
reperfusion varying from 59% to 82% in the past.2 Overall, AIVR
was observed in 82/200 (41%) patients. Demographic variables
and cardiac risk factors are listed in Table 1. The patients with
and without AIVR were comparable in terms of age, gender, MI
location, and left ventricular ejection fraction (LVEF).
AIVR was seen in 31 patients (35%) with failed thromboly-
sis and 51 patients (45%) with successful thrombolysis
( p = 0.17) (Table 2). The sensitivity and speciﬁcity of AIVR
for predicting successful reperfusion were found to be 45%
and 64% respectively. Early AIVR was seen in 23 (28%) while
late AIVR was seen in (72%) patients. Early AIVR was more
common in successfully thrombolysed patients ( p < 0.05)
(Table 3). The sensitivity of early AIVR was low (45%);
however, the speciﬁcity and the positive predictive value
were excellent; of the 25 patients with early AIVR, 23 had
successful thrombolysis.
Table 1 – Clinical profile of patients with and without
AIVR.
AIVR
(n = 82)
No AIVR
(n = 118)
p value
Age 59  10.8 58  10.6 0.86
Gender (M/F) 56/36 62/56 0.91
Smoking 48 70 0.68
Diabetes 44 53 0.63
Hypertension 52 63 0.74
Dyslipidemia 27 24 0.32
Anterior infract/
inferior infract
39/43 55/63 0.80
LVEF 40  0.7 39  0.5 1.00
Cardiogenic shock 10 23 0.792
Death 2 9 0.291
Table 3 – Early AIVR in both groups.
Successful
thrombolysis
Failed
thrombolysis
Total p value
Early AIVR 23 2 25 <0.05
Late AIVR 28 29 57
Total 51 31 82
Table 2 – AIVR in patients with Successful and failed
thrombolysis.
Successful
thrombolysis
Failed
thrombolysis
Total p value
AIVR 51 31 82 0.17
No AIVR 62 56 118
Total 113 87 200
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The ECG remains the best modality for diagnosing reperfusion
in acute MI and has been so utilized in all major thrombolytic
trials.9–10 While angiography may show excellent epicardial
ﬂow, failure of ST resolution in such patients would indicate
poor myocardial perfusion. In fact, Eric Topol in a recent
article11 called the ECG as the ‘‘Platinum Standard’’ for
diagnosing reperfusion. The ST segment resolution has been
the standard measurement in this regard. However, at times
when this measurement is borderline, an additional marker
would be very useful. Additionally, ST resolution becomes
difﬁcult to assess with bundle branch block and also when the
initial ST elevation is not much. Reperfusion arrhythmias,
especially AIVR, have for long been debated as markers of
successful reperfusion. AIVR had been proposed as a speciﬁc
non-invasive marker for successful reperfusion, even in the
pre-thrombolytic era.3 In this study, we found early AIVR to be
a reliable marker of successful reperfusion following STK.
In the present study, the incidence of AIVR was slightly
lower (41%) than previously reported (42–88%).12–14 In recent a
study by Tatli et al.,5 the incidence of AIVR in successfully
thrombolysed patients was 73%, which was much more than
that (45%) in our study. In a study by Chiladakis,4 the presence
of AIVR combined with normalization of ST segments wasdemonstrated to indicate successful reperfusion in patients
treated with thrombolytics. Also, rates of AIVR occurring in the
ﬁrst 6 h were found signiﬁcantly higher in patients with
arterial patency and these arrhythmias were deﬁned as non-
invasive indicators of early coronary reperfusion.3 Other
studies14,15 also reported AIVR as a useful marker for
reperfusion. However, Califf et al.6 found that although
arrhythmias occurred frequently in the ﬁrst 90 min of therapy,
none were associated with a higher patency rate. Similarly
Gore et al.7 and Hacket et al.8 did not ﬁnd AIVR to be associated
with successful reperfusion. Gressin et al.12 found that
arrhythmia rates (including AIVR) in patients with Thrombol-
ysis In Myocardial Infarction grade (TIMI grade) 2 and 3 ﬂow
grades and in those without arterial patency (TIMI 0 or 1 ﬂow
grades) were similar.
In the era of PAMI, the prognostic relevance of AIVR remains
unclear.16–18 In a study by Terkelsen et al.,19 the most common
arrhythmia observed during PAMI was AIVR (42%). Some other
studies of PAMI in patients with STEMI suggested that AIVR is a
marker of a reopened artery, but not necessarily a marker for
complete reperfusion. Heper et al.20 found AIVR to be associated
with more extensive myocardial damage and delayed micro-
vascular reperfusion. In the present study, early AIVR was more
common in successfully thrombolysed patients ( p < 0.05).
Though the sensitivity and negative predictive value were
low, the speciﬁcity and positive predictive value were very good.
This was comparable to the ﬁndings of Chiladakis and
coworkers,4 who reported a sensitivity of 38% and a speciﬁcity
of 96%.
In conclusion, our study has reinforced the fact that AIVR is
a common reperfusion arrhythmia after thrombolysis with
STK in the current era. Early AIVR (within 2 h of thrombolytic
therapy) has a very good positive predictive value for
successful reperfusion.
Limitations: The study was carried out at a single center and
the sample size was small. The presence of AIVR was not
compared with outcomes in patients. In view of the contra-
dictory reports regarding outcomes, there is a further need of
studies with larger number of patients to clarify its clinical
signiﬁcance. The patency of the infarct related artery was not
conﬁrmed angiographically in the study.
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